19E: Affiliate Organisation Session - Key global challenges in addressing (re)emerging STIs. Developed by WHO
Tracks
Track 5
| Friday, September 20, 2024 |
| 1:30 PM - 3:00 PM |
| C2.5 |
Details
Chairs
Remco Peters World Health Organization
Nick Medland, Kirby Institute UNSW
The burden of STIs is increasing globally including the (re)emergence of syphilis and mpox. Addressing key clinical and programmatic challenges is imperative to control these epidemic. This symposium aims to provide a global and regional perspective by providing context from the WHO perspective, showing lessons learnt in successful programmes and identifying key priorities to close clinical and programmatic gaps towards control.
Remco Peters World Health Organization
Nick Medland, Kirby Institute UNSW
The burden of STIs is increasing globally including the (re)emergence of syphilis and mpox. Addressing key clinical and programmatic challenges is imperative to control these epidemic. This symposium aims to provide a global and regional perspective by providing context from the WHO perspective, showing lessons learnt in successful programmes and identifying key priorities to close clinical and programmatic gaps towards control.
Speaker
Dr Remco Peters
Medical Officer
World Health Organization
Setting the scene: global perspective on emerging STIs
1:30 PM - 1:40 PMBiography
Dr Peters leads the STI care and treatment programme at the WHO since this year. He has almost 20 years’ experience working as clinician, epidemiologist, and researcher in the STI and HIV fields in low-resource settings across Southern Africa.
Mr William Pomat
Speaker
Unsw/aphp
Implementation of syphilis and other rapid diagnostic tests in healthcare programmes
1:50 PM - 2:00 PMBiography
Professor Michael Marks
Professor Of Medicine
London School of Hygiene and Tropical Medicine
Treatment of syphilis in pregnancy when BPG is unavailable
2:00 PM - 2:10 PMBiography
Michael Marks is Professor of Medicine at LSHTM and an Honorary Consultant in Infectious Diseases at the Hospital for Tropical Diseases, University College London Hospital. His major area of interest has been the epidemiology and control of Treponema pallidum including using next-generation sequencing approaches, evaluating Linezolid as a new oral therapy for syphilis investigating integrating near-patient diagnostics for STIs into antenatal care in Zimbabwe.
Prof Dimie Ogoina
Chief Medical Director
Niger Delta University Teaching Hospital, Bayelsa, Nigeria
Clinical management of mpox in the context of HIV and STIs in Africa
2:10 PM - 2:20 PMBiography
Dimie Ogoina is a Professor of Medicine and Infectious Diseases and an infectious diseases physician. He was listed in Nature’s top 10 scientists in 2022 and recognized as one of Time's 100 most influential persons in 2023 for his groundbreaking research on mpox and contributions to health equity.
Mr Dash Heath-Paynter
CEO
Health Equity Matters
The Australian mpox response: a partnership of health sector, policy makers and community
2:20 PM - 2:40 PMBiography
Dash Heath-Paynter is the CEO of Health Equity Matter. Health Equity Matters leads Australia’s community-controlled response to HIV as the sector’s peak body. The organisation delivers programming to build the capacity of its member organisations across Australia and implementing partners in Asia and the Pacific to support efforts to meet local and international targets to virtually eliminate HIV transmission.
Dr Lucia Romani
Senior Research Fellow
Kirby Institute, Unsw Sydney
Is scabies incidence and drug resistance on the rise?
2:40 PM - 2:50 PMBiography
Dr Lucia Romani is an epidemiologist and Lead of the Global Health Trials Research Group at the Kirby Institute, UNSW Sydney. She has over 15 years’ experience leading community intervention strategies for the control of infectious diseases, focusing on neglected tropical diseases and sexually transmitted infections in low and middle-income countries.
Chair
Nick Medland
Senior Research Fellow
Kirby Institute UNSW
Remco Peters
Medical Officer
World Health Organization
